Soft tissue injuries have a way of turning athletes into supplement shoppers. A quick search for the best supplements for healing tendons and ligaments returns an overwhelming list of products, each promising accelerated recovery, yet most of that advice collapses under scrutiny because it ignores the biological specifics that actually determine whether a supplement does anything useful.
The evidence on tendon and ligament repair is more precise than most generic guidance suggests. Collagen synthesis follows a narrow, exercise-triggered window. Dosing and co-supplementation requirements are well-defined in the research. And the structural differences between tendons and ligaments raise legitimate questions about whether a single protocol applies to both tissues equally.
This analysis cuts through the marketing noise and builds a recovery framework grounded in current clinical evidence. You will learn how these tissues are constructed and damaged, what the research actually demonstrates about collagen supplementation and vitamin C timing, which synergistic nutrients have earned their place in the protocol, and how supplementation strategy should shift across the acute, subacute and chronic phases of recovery. The goal is a protocol a recovering athlete can execute with precision, not just a list of ingredients to chase.
Why Generic Supplement Advice Misses the Clinical Window
The supplement market offers no shortage of collagen products, amino acid blends and connective tissue formulas. What most of them do not offer is any guidance on when to take them, why timing matters, or whether the product is designed for daily maintenance or active injury repair. That distinction is not a minor detail; it determines whether supplementation does anything useful at all.
Collagen synthesis is not a continuous background process that responds proportionally to whatever you consume. It is an exercise-coupled biological event, elevated in a specific window following targeted loading of connective tissue. Supplementing outside that window is substantially less effective, yet this mechanism is absent from virtually all commercial product labelling.
The conflation runs deeper than timing. Generic advice treats supplementation as a single category, when structural maintenance and injury repair are physiologically distinct. The subacute repair phase, when fibroblasts are actively laying down new collagen, requires different dosages, specific co-supplementation (vitamin C is not optional, as later sections explain), and timing precision that a standard “take two capsules daily” instruction cannot deliver.
The research base has grown considerably. Systematic reviews published between 2021 and 2025 across journals including Sports Medicine, Amino Acids and Orthopedic Reviews have examined collagen peptide supplementation in musculotendinous remodelling, functional recovery and connective tissue repair with increasing rigour. The findings are specific about dosage, form and timing. Commercial products have not kept pace with that specificity.
For a broader review of what the evidence actually supports, the Supplements: What the Evidence Says resource provides useful grounding.
At PSM, clinical management begins with accurate diagnosis and a structured plan. Supplementation should follow the same logic: knowing what tissue is injured, which repair phase you are in, and what the biology requires at that stage is what determines the protocol.
How Tendons and Ligaments Are Actually Built
To understand why protocol matters more than ingredient lists, you need to understand what these tissues are made of and how that structure is maintained.
Both tendons and ligaments are dense connective tissues built primarily from Type I collagen, which accounts for approximately 80% of tendon dry mass. Type I collagen is assembled from non-essential amino acids, principally glycine, proline, hydroxyproline and hydroxylysine. “Non-essential” refers to the body’s ability to synthesise them, not their importance; during active repair, demand for these amino acids rises substantially, and their availability directly influences the rate and quality of collagen production.
Tendons transmit force from muscle to bone; ligaments connect bone to bone and stabilise joints under load. Both depend on a parallel arrangement of collagen fibres to do this effectively. That architecture is not incidental to their function; it is their function. Disruption to fibre organisation is what produces pain, weakness and instability in both injury types.
The structural similarity means many nutritional interventions target the same biochemical pathway in both tissues. However, research on Type I collagen cross-linking shows that tendon and ligament collagen are not identical in their cross-linking profiles. Blood supply and repair timelines also differ, and these variables influence how supplementation protocols should be applied across tissue types, a distinction explored in detail later in this piece.
This architecture is precisely why the best supplements for tendons and ligaments are not standard protein powders. Muscle protein synthesis and connective tissue collagen synthesis are separate biological processes. Connective tissue repair requires compounds that support the enzymatic cross-linking reactions that give repaired collagen its tensile strength, not simply a higher amino acid load. Our Tendon Clinic applies this understanding to the clinical management of tendon injury, beginning with the tissue-level diagnosis that determines what the repair process actually needs.
What Happens at the Tissue Level When Tendons and Ligaments Are Injured
When organised architecture breaks down, the clinical consequences are specific and predictable.
In tendinopathy, collagen fibres lose their parallel alignment, become disorganised, and the tissue loses its capacity to transmit load efficiently. The result is load-dependent pain and weakness, not from inflammation alone, but from a structural deficit within the matrix itself.
Ligament sprains follow a different mechanical pattern: partial or complete disruption of fibre bundles caused by forces exceeding tensile tolerance. Healing quality is shaped by three variables: local vascular supply (which varies by anatomical site), the mechanical loading environment during recovery, and substrate availability for new collagen synthesis. All three are modifiable, and the third is directly relevant to nutritional intervention.
The repair sequence that determines outcome
Following acute injury, an initial inflammatory phase clears damaged tissue and initiates repair. Fibroblasts then enter the proliferative phase, synthesising new extracellular matrix to bridge the injury site. The critical point: collagen produced during proliferation is not automatically Type I. When substrate availability is limited, fibroblasts produce Type III collagen, which cross-links rapidly and provides provisional stability but is weaker and less organised than the mature Type I collagen it should eventually replace. Poorly supported repair stalls at this stage. Targeted nutritional support during proliferation and remodelling is therefore a clinical consideration, not a wellness preference.
Chronic tendinopathy presents a distinct problem. The disorganised matrix is already established; there is no acute repair window to target. Supplementation here must support the remodelling response driven by progressive mechanical loading, which is a meaningfully different protocol. Understanding the full spectrum of musculoskeletal treatment options helps clarify where nutrition fits within a structured plan rather than sitting alongside it as an afterthought.
What the Evidence Actually Shows for Collagen Supplementation
Given that tissue-level repair depends on substrate availability, the logical next question is whether supplementation actually delivers those substrates where they are needed. The answer depends significantly on which form of collagen you take.
The strongest current evidence comes from systematic reviews published between 2021 and 2025 in peer-reviewed journals including Orthopedic Reviews, which identify Type I collagen hydrolysate as the best-supported form for connective tissue repair. The distinction between formulation types is not a minor detail; it determines how much usable substrate actually reaches the tissue.
Hydrolysed collagen (collagen peptides) undergoes enzymatic processing that breaks the protein into smaller peptides, typically 1,000 to 2,500 Daltons in molecular weight. A randomised, double-blind crossover study found that approximately 40% of collagen peptides are absorbed in peptide-bound form, achieving higher plasma concentrations of key amino acids than intact or partially hydrolysed sources. That bioavailability advantage is directly relevant when tissue repair creates a genuine demand for glycine, proline and hydroxyproline.
Gelatin is partially hydrolysed collagen and has produced positive outcomes in some exercise-timed protocols. It is a lower-cost option, but batch-to-batch variability in peptide composition makes it unsuitable as a reliable substitute when precise dosing matters clinically.
Whole food sources such as bone broth are nutritionally relevant but provide inconsistent peptide concentrations. They cannot establish the dose-response relationships required to assess efficacy in injury management.
On dosage, the most cited studies use 5 to 15g of hydrolysed collagen daily, with 10 to 15g in protocols specifically targeting connective tissue repair. Most commercial products do not specify this range on their labelling, which means athletes relying on product guidance alone are unlikely to be using clinically relevant doses. This same gap in evidence-to-practice translation applies to injectable therapies; understanding how the evidence is applied in clinical contexts demonstrates why protocol specificity matters across all treatment modalities.
Vitamin C Is Not Optional: The Co-Supplementation Requirement
Knowing the right form and dose of collagen is only part of the equation. Without adequate vitamin C present at the point of synthesis, much of that substrate cannot be used effectively.
Ascorbic acid is an essential cofactor for two enzymes central to collagen production: prolyl hydroxylase and lysyl hydroxylase. These enzymes hydroxylate proline and lysine residues within the collagen chain, a step that is chemically required for the triple helix structure to form and stabilise correctly. Without sufficient vitamin C, this hydroxylation is impaired and structurally sound collagen cannot be assembled, regardless of how much hydrolysate is present.
Cell culture research has examined how vitamin C affects collagen synthesis and enzymatic expression in fibroblast models, supporting the mechanistic basis for co-supplementation. The clinical translation is direct: co-supplementation is not a refinement of the protocol, it is a prerequisite for it.
This matters practically because standalone collagen supplementation, taken without concurrent vitamin C, is supported by substantially weaker evidence. The well-designed protocols that produced positive outcomes in connective tissue research used both compounds together. Replicating those outcomes requires replicating that approach.
A modest dose of vitamin C, consistent with the amounts used in the positive-outcome collagen trials, should be taken alongside the collagen supplement. This is not a high-dose megadose regimen. Excessive vitamin C intake is not without its own considerations, and more is not better here.
Vitamin C is water-soluble and cleared relatively quickly, with depletion accelerated by physiological stress including intense exercise. Athletes in an active repair phase cannot reliably assume their background dietary intake is sufficient. Timed co-supplementation, taken together with collagen at the point of use, is the only reliable way to ensure both substrates are available simultaneously when the tissue needs them.
Timing: The Part of the Protocol Most Supplements Ignore
Knowing what to take gets you halfway there. Knowing when to take it is where most supplement protocols fall short.
Post-exercise plasma glycine levels decline measurably, reflecting increased utilisation during the collagen synthesis response triggered by loading. Research from Maastricht University demonstrated that glycine availability over the 360 minutes following exercise was strongly negative when whey protein was taken alone, confirming that connective tissue draws heavily on glycine reserves after training. The practical implication: if amino acid substrates are not available before that synthesis window opens, the tissue is working with depleted resources.
The Pre-Exercise Protocol
Collagen synthesis markers are elevated in the hours following targeted tendon or ligament loading. A double-blind crossover study published in The Journal of Nutrition examined pre-exercise collagen ingestion and found that it produced significantly greater procollagen synthesis markers over the post-exercise period compared to no supplementation. The protocol that current evidence most clearly supports involves hydrolysed collagen taken approximately 30–60 minutes before a rehabilitation loading session, with vitamin C co-administered; the highest-quality study used 30g with 50mg vitamin C, while broader systematic review evidence supports 10–15g as a clinically practical range.
This is the counterintuitive part for most athletes. Post-workout protein supplementation is the established norm for muscle, but connective tissue follows a different kinetic profile. Muscle protein synthesis responds well to post-exercise amino acid delivery; collagen synthesis responds to substrate availability ahead of the loading stimulus. The protocols are not interchangeable.
On Rest Days and Non-Loading Phases
During acute injury phases when mechanical loading is restricted, the pre-exercise timing rationale does not apply. Twice-daily dosing, spaced evenly across the day, better sustains amino acid availability during the inflammatory and early proliferative phases. If you are managing tendon recovery alongside injection therapy, the guidance on recovery after a high-volume tendon injection covers the loading restrictions that affect how you should structure supplementation timing in that specific context.
Finally, consistency matters more than precision on any single day. Connective tissue remodelling operates on a significantly longer time course than muscle adaptation, and supplementation windows of two to four weeks are unlikely to produce measurable structural outcomes. Eight to twelve weeks is the minimum meaningful duration, a point addressed in full later in this piece.
Beyond Vitamin C: Synergistic Nutrients That Support Collagen Synthesis
Timing determines whether collagen substrates are available when tissue needs them. But delivery only matters if the right substrates are present in the first place.
Proline and lysine are the primary amino acids incorporated into the collagen triple helix. Both are classified as non-essential, meaning the body can synthesise them, but dietary and supplemental sources become conditionally important during active repair in a way they are not during normal training.
Copper is a required cofactor for lysyl oxidase, the enzyme that catalyses cross-linking between collagen molecules. Cross-linking is what confers tensile strength to repaired tissue; without adequate copper, newly synthesised collagen remains mechanically inferior regardless of how much substrate has been delivered. Deficiency is uncommon in a varied diet, but athletes with restricted energy intake or poor dietary diversity are at risk.
Iron is required for the hydroxylation reactions that stabilise the triple helix structure. Low iron status, which is disproportionately prevalent in endurance athletes and in female athletes particularly, can impair collagen synthesis even when every other substrate is adequate. This makes iron status a practical clinical consideration in any athlete presenting with slow connective tissue recovery.
Zinc supports fibroblast proliferation and regulates matrix metalloproteinases (MMPs), the enzymes responsible for remodelling disorganised collagen into aligned, load-bearing architecture. Suboptimal zinc status may delay this transition, prolonging the period of structural vulnerability in healing tissue.
Manganese is a cofactor for prolidase, an enzyme involved in recycling proline from degraded collagen back into the synthesis pool. It receives little attention in supplement protocols, but it forms part of the micronutrient infrastructure that keeps collagen turnover efficient.
The mechanistic roles of these micronutrients in collagen biochemistry are well-established in the broader literature; the clinical trial evidence specifically linking supplementation of each to accelerated tendon or ligament repair in athletes remains limited.
The practical conclusion is straightforward: a whole-food diet adequate in protein, diverse in micronutrients and sufficient in energy forms the non-negotiable foundation. Targeted supplementation with collagen and vitamin C is an adjunct to that foundation, not a substitute for it.
Tendon vs. Ligament Repair: Does the Same Protocol Apply?
The same enzymatic processes covered above apply equally to ligament tissue, which raises a legitimate clinical question: if the biochemistry is shared, does the supplementation protocol transfer?
The honest answer is: probably, but the ligament-specific evidence to confirm this with precision does not yet exist. Researchers have noted that clinical trials in ligament repair substantially lag those in tendon research, and content claiming equivalent evidence bases for both tissues overstates what the literature currently supports.
What the evidence does confirm is a strong mechanistic case for extrapolation. The shared biochemical substrate, discussed in detail earlier, means the nutritional rationale transfers; what the ligament-specific literature cannot yet confirm is the clinical magnitude of that benefit.
Several structural differences are worth acknowledging, however. Ligaments tend to have a poorer vascular supply in certain anatomical locations, which may affect how efficiently nutritional substrates reach the repair site. Critically, most ligament injuries are discrete traumatic events, such as ankle sprains or ACL tears, rather than the gradual degenerative process that defines tendinopathy. This shifts the supplementation focus toward supporting the proliferative phase of acute repair and the quality of the collagen matrix being laid down during that window.
For patients managing ligament injuries, PSM applies the same structured pathway used in advanced tendon rehabilitation: accurate diagnosis, a clear plan, appropriate intervention, expert rehabilitation and a return-to-performance programme. Nutritional support sits within the rehabilitation and intervention phases of that pathway.
Where ligament-specific evidence is absent, clinical reasoning grounded in shared tissue biology is a defensible framework. It should, however, be applied under clinical guidance rather than through self-directed protocol adoption.
Supplementation Across Recovery Phases: Acute, Subacute and Chronic
Translating the shared tissue biology into practice means applying the right nutritional strategy at each stage of recovery, because the biological priorities shift significantly across the repair timeline.
Acute phase (0–2 weeks). The inflammatory environment is active and necessary. The goal here is not to maximise collagen loading but to ensure dietary adequacy in protein, vitamin C and key micronutrients. This creates the nutritional platform that the proliferative phase will depend on. Aggressive supplementation is not warranted; substrate deficiency is what you are guarding against.
Subacute phase (2–8 weeks). This is the primary intervention window. The proliferative phase is biologically active, fibroblasts are laying down new collagen, and targeted supplementation has its strongest mechanistic rationale. This is also the phase where the pre-exercise timing protocol (10–15g collagen with vitamin C, 30–60 minutes before loading) has its strongest application. Timing supplementation to precede loading aligns substrate delivery with the tissue’s synthesis window.
Chronic tendinopathy and late-stage rehabilitation. Progressive loading is the primary driver of collagen remodelling at this stage. Supplementation functions to ensure substrate availability does not limit the tissue’s response to exercise, not to substitute for it. Post-surgical contexts, including ACL reconstruction and Achilles repair, represent the clearest clinical indication for structured supplementation, but dosage and duration must be aligned with the surgical and rehabilitation protocol. Generic application is not appropriate here; oversight matters.
Duration is non-negotiable. Structural connective tissue outcomes require a minimum of 8–12 weeks of consistent supplementation. Shorter trials are unlikely to produce measurable change, which accounts for much of the mixed anecdotal feedback athletes report.
Across every phase, supplementation supports a structured programme. It does not replace loading, progressive exercise or clinical management. Understanding which level of care your injury requires is itself a meaningful first step; a guide to finding the right specialist for your injury can help clarify where to start.
Where Oral Supplementation Fits Alongside Clinical Intervention
Supplementation does not exist in a vacuum. For many patients managing tendon or ligament injuries, oral nutrition forms one layer of a broader clinical picture that may also include injectable therapies or procedural interventions.
PRP, hyaluronic acid and high-volume injections are used at PSM in specific clinical contexts. They are not appropriate for every presentation, and selecting the right candidate requires accurate diagnosis and a clear understanding of tissue pathology. PRP functions by delivering a concentrated release of growth factors that stimulate fibroblast recruitment and collagen synthesis. Oral collagen supplementation targets the same downstream biology: it provides the amino acid substrates those fibroblasts require to produce new collagen. The two approaches are not in competition. If anything, ensuring adequate nutritional substrate availability before and during an injection therapy course means the biological environment is better equipped to respond to the growth factor stimulus. The relationship is complementary, not either-or.
The same logic applies to shockwave therapy, which PSM uses for chronic tendinopathy. Shockwave drives collagen remodelling and promotes neovascularisation in degenerative tissue. Pairing it with targeted collagen and vitamin C supplementation during a treatment course ensures that the tissue has the precursor availability to act on that stimulus. It is a clinically reasonable adjunct, even where direct trial evidence for the combined approach remains limited.
What determines whether any of these interventions is appropriate is diagnosis. At PSM, that assessment may include diagnostic ultrasound or MRI, which establishes the structural picture that guides every subsequent decision, including whether oral supplementation is the appropriate focus, whether injectable therapy is indicated, or whether the clinical picture warrants surgical consultation.
Patients who self-manage with supplements while avoiding assessment carry a genuine risk: the diagnosis that would change the entire treatment direction remains unknown. Understanding what specialist sports injury care actually looks like starts with getting that clinical picture right.
A Practical Protocol Summary: What to Take, When and for How Long
With the clinical context established, here is the protocol distilled into practical terms.
On loading days, take 10–15g of hydrolysed collagen (collagen peptides) alongside vitamin C, 30–60 minutes before rehabilitative exercise or targeted loading. This timing positions amino acid availability to coincide with the post-exercise elevation in collagen synthesis. The collagen-plus-vitamin-C combination carries the strongest mechanistic and emerging clinical support for tendon and ligament repair.
On rest days, follow the twice-daily spacing outlined in the Timing section above.
Duration is non-negotiable. Connective tissue remodelling operates on a longer time course than muscle adaptation. A minimum of 8–12 weeks of consistent supplementation is required for any meaningful structural effect. Treat it as a rehabilitation variable, not a short-term trial.
On supplement form: hydrolysed collagen (collagen peptides) is the preferred choice, offering superior bioavailability through more efficient peptide absorption. Gelatin is a viable lower-cost alternative for pre-exercise protocols, but its batch-to-batch variability in peptide composition makes precise dosing less reliable over a structured rehabilitation period.
Supporting micronutrients (copper, zinc, iron and manganese) underpin the enzymatic processes that build and cross-link collagen. In a well-nourished athlete eating a varied diet, isolated supplementation is rarely necessary. However, those following restrictive diets, carrying high training loads, or with known deficiencies should have micronutrient status assessed as part of their clinical picture.
This framework is a starting point, not a clinical prescription. Anyone managing a specific injury, post-surgical recovery or complex nutritional history should have supplementation guidance integrated into their overall management plan rather than applied in isolation.
The Bottom Line on Tendon and Ligament Supplementation
The protocol framework above is only as effective as the injury assessment that underpins it. As the evidence sections establish, hydrolysed collagen plus vitamin C, timed around loading and sustained for at least 8–12 weeks, forms the protocol core, and the same framework applies to ligament repair, with the caveat that tissue-specific clinical validation remains limited.
Single-ingredient marketing and non-specific daily dosing miss the biological window that makes connective tissue supplementation meaningful. The evidence supports mechanism-led, protocol-based use, not broad-spectrum ingredient lists selected on the basis of brand positioning.
For active individuals and athletes managing a tendon or ligament injury, the most important first step remains accurate diagnosis. Knowing precisely what tissue is involved, what phase of repair you are in, and what the injury requires determines everything that follows, including whether supplementation, injection therapy, shockwave or a combination of approaches is appropriate.
At Pro Sports Medicine in Cardiff, our clinical team provides exactly that starting point: specialist assessment, advanced diagnostics and a clear pathway from diagnosis through to return to performance.
Conclusion
Tendon and ligament repair is a biology-driven process, and supplementation works only when it respects that biology. The evidence is clear on several points: collagen peptides paired with vitamin C, dosed strategically around loading sessions, support tissue synthesis in ways that random daily supplementation cannot. Timing matters. Phase of recovery matters. And the distinction between tendons and ligaments, while nuanced, does not invalidate a shared, evidence-based approach.
Supplementation accelerates what the body is already trying to do; it does not replace the clinical work that makes recovery possible.
If you are managing a connective tissue injury and want a protocol built around your specific diagnosis, loading stage and performance goals, our team at Pro Sports Medicine in Cardiff is ready to help. Start with the right assessment, and everything else follows from there.
